Wellington Management Group LLP Sells 18,885 Shares of Phibro Animal Health Corporation $PAHC

Key Points

• Wellington Management Group LLP reduced its stake in Phibro Animal Health Corporation by 23.0%, selling 18,885 shares during the first quarter, leaving them with 63,113 shares valued at approximately $1.35 million.
• Phibro Animal Health recently reported a quarterly earnings result of $0.57 EPS, which exceeded the expected $0.52 EPS, and set its FY 2026 guidance between $2.520 and $2.700 EPS.
• The company declared a quarterly dividend of $0.12 per share, reflecting a 1.3% dividend yield and a payout ratio of 40.68%.

Wellington Management Group LLP trimmed its position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 23.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,113 shares of the company's stock after selling 18,885 shares during the period. Wellington Management Group LLP owned approximately 0.16% of Phibro Animal Health worth $1,348,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of PAHC. Vanguard Group Inc. increased its position in Phibro Animal Health by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock worth $32,500,000 after purchasing an additional 6,784 shares during the last quarter. Nuveen Asset Management LLC increased its holdings in shares of Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after buying an additional 103,618 shares during the last quarter. Nuveen LLC bought a new stake in shares of Phibro Animal Health in the 1st quarter worth about $10,312,000. CastleKnight Management LP raised its position in shares of Phibro Animal Health by 6.2% during the 4th quarter. CastleKnight Management LP now owns 389,433 shares of the company's stock valued at $8,178,000 after buying an additional 22,796 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in shares of Phibro Animal Health by 92.3% in the 1st quarter. Invesco Ltd. now owns 387,739 shares of the company's stock valued at $8,282,000 after acquiring an additional 186,087 shares during the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Trading Up 3.5%

Shares of Phibro Animal Health stock traded up $1.33 on Thursday, hitting $39.53. 187,287 shares of the company traded hands, compared to its average volume of 271,805. The company has a current ratio of 2.76, a quick ratio of 1.23 and a debt-to-equity ratio of 2.46. The company has a market cap of $1.60 billion, a PE ratio of 33.25, a PEG ratio of 0.54 and a beta of 0.89. The stock's 50 day moving average price is $30.10 and its 200-day moving average price is $24.71. Phibro Animal Health Corporation has a 52 week low of $16.16 and a 52 week high of $39.91.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.52 by $0.05. The company had revenue of $378.70 million for the quarter, compared to the consensus estimate of $362.24 million. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. Equities research analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be paid a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. Phibro Animal Health's dividend payout ratio (DPR) is currently 40.68%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Bank of America lifted their price target on Phibro Animal Health from $19.00 to $27.00 and gave the stock an "underperform" rating in a research report on Friday, August 29th. BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price for the company in a report on Monday, June 16th. Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Zacks Research downgraded Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 28th. Finally, BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Reduce" and a consensus target price of $28.40.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.